In October 2024, Imuldosa received approval from the Food and Drug Administration based on data from the phase 3 Opportuniti ...

Results of a cross-sectional study in India showed that a significant percentage of adults with RA are intolerant to MTX.

Providers should consider preemptively tapering opioids, implementing behavioral therapy, and administering nonopioid analgesics.

Benevolent childhood experiences reduce the risk for disordered eating behaviors later in life, while adverse experiences increase it.

The FDA has issued a CRL to PTC Therapeutics regarding the NDA for vatiquinone for the treatment of children and adults living with Friedreich ataxia.

Serum levels of vascular endothelial growth factor and IL-1 receptor antagonist decreased significantly after genicular artery embolization.

The divergence between male and female sleep quality starts at puberty and has several implications for women’s health across ...

Improved functional and survival outcomes were seen with risdiplam treatment before development of clinical signs or symptoms.